View more from Listerine
Switch to Dark theme

References

O'Reilly PG, Claffey NM. A history of oral sepsis as a cause of disease. Periodontol 2000. 2000; 23:13-18
Mayo CH. Focal infection of dental origin. Dental Cosmos. 1922; 64:1206-1208
Hunter W. Oral sepsis as a cause of disease. Br Med J. 1900; 2:215-216
Mattila KJ, Nieminen MS, Valtonen VV Association between dental health and acute myocardial infarction. Br Med J. 1989; 298:779-781
Scannapieco FA. Position paper of The American Academy of Periodontology: periodontal disease as a potential risk factor for systemic diseases. J Periodontol. 1998; 69:841-850
Mustapha IZ, Debrey S, Oladubu M, Ugarte R. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodontol. 2007; 78:2289-2302
Heo SM, Haase EM, Lesse AJ, Gill SR, Scannapieco FA. Genetic relationships between respiratory pathogens isolated from dental plaque and bronchoalveolar lavage fluid from patients in the intensive care unit undergoing mechanical ventilation. Clin Infect Dis: an official publication of the Infectious Diseases Society of America. 2008; 47:1562-1570
Han YW. Oral health and adverse pregnancy outcomes – what's next?. J Dent Res. 2011; 90:289-293
Molina CA, Ojeda LF, Jiménez MS Diabetes and periodontal diseases: an established two-way relationship. J Diabetes Mellitus. 2016; 6:209-229
Kaur S, Bright R, Proudman SM, Bartold PM. Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis. Semin Arthritis Rheum. 2014; 44:113-122
Strauss J, Kaplan GG, Beck PL Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis. 2011; 17:1971-1978
Castellarin M, Warren RL, Freeman JD Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012; 22:299-306
Han P, Sun D, Yang J. Interaction between periodontitis and liver diseases. Biomed Rep. 2016; 5:267-276
Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol. 1996; 67:1123-1137
Thoden van Velzen SK, Abraham-Inpijn L, Moorer WR. Plaque and systemic disease: a reappraisal of the focal infection concept. J Clin Periodontol. 1984; 11:209-220
Roberts GJ. Dentists are innocent! “Everyday” bacteremia is the real culprit: a review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children. Pediatr Cardiol. 1999; 20:317-325
Que YA, Moreillon P. Infective endocarditis. Nat Rev Cardiol. 2011; 8:322-336
Douglas CWI, Heath J, Hampton KK, Preston FE. Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol. 1993; 39:179-182
Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000; 71:1554-1560
Lamont RJ, Hajishengallis GN, Jenkinson HF., 2nd edn. Washington DC, USA: ASM Press; 2014
Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev. 2000; 13:547-558
Van Dyke TE, Dowell VR, Offenbacher S, Snyder W, Hersh T. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun. 1986; 53:671-677
Bhatnagar P, Wickramasinghe K, Williams J, Rayner M, Townsend N. The epidemiology of cardiovascular disease in the UK 2014. Heart. 2015; 101:1182-1189
Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999; 340:115-126
Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011; 473:317-325
Scannapieco FA, Bush RB, Paju S. Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol/The American Academy of Periodontology. 2003; 8:38-53
Burazor I, Vojdani A. Chronic exposure to oral pathogens and autoimmune reactivity in acute coronary atherothrombosis. Autoimmune Dis. 2014; 2014
Hart RG, Foster JW, Luther MF, Kanter MC. Stroke in infective endocarditis. Stroke. 1990; 21:695-700
Syrjanen J, Peltola J, Valtonen V, Iivanainen M, Kaste M, Huttunen JK. Dental infections in association with cerebral infarction in young and middle-aged men. J Intern Med. 1989; 225:179-184
Hashemipour MA, Afshar AJ, Borna R, Seddighi B, Motamedi A. Gingivitis and periodontitis as a risk factor for stroke: a case-control study in the Iranian population. Dental Res J (Isfahan). 2013; 10:613-619
Zeerleder S, Hack CE, Wuillemin WA. Disseminated intravascular coagulation in sepsis. Chest. 2005; 128:2864-2875
Herzberg MC, Meyer MW. Effects of oral flora on platelets: possible consequences in cardiovascular disease. J Periodontol. 1996; 67:1138-1142
Shannon O. Platelet interaction with bacterial toxins and secreted products. Platelets. 2015; 26:302-308
Shenep JL. Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrobial Agents. 2000; 14:129-135
Thornhill MH, Dayer M, Lockhart PB Guidelines on prophylaxis to prevent infective endocarditis. Br Dent J. 2016; 220:51-56
Prendergast BD. The changing face of infective endocarditis. Heart. 2006; 92:879-885
Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol. 2006; 4:445-457
Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis. Lancet. 2015; 385:1219-1228
Yeaman MR. Bacterial-platelet interactions: virulence meets host defense. Future Microbiol. 2010; 5:471-506
Khurana I.: Elsevier India; 2006
Rendu F, Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets. 2001; 12:261-273
Bennett JS, Berger BW, Billings PC. The structure and function of platelet integrins. J Thromb Haemost. 2009; 7:200-205
Kerrigan SW. The expanding field of platelet-bacterial interconnections. Platelets. 2015; 26:293-301
Wu T, Yeaman MR, Bayer AS. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates. Antimicrob Agents Chemother. 1994; 38:729-732
Deng L, Bensing BA, Thamadilok S Oral streptococci utilize a siglec-like domain of serine-rich repeat adhesins to preferentially target platelet sialoglycans in human blood. PLoS Pathogens. 2014; 10
Svensson L, Baumgarten M, Mörgelin M, Shannon O. Platelet activation by Streptococcus pyogenes leads to entrapment in platelet aggregates, from which bacteria subsequently escape. Infect Immun. 2014; 82:4307-4314
Clawson CC. Platelet interaction with bacteria. 3. Ultrastructure. Am J Pathol. 1973; 70:449-471
Clawson CC, Rao GH, White JG. Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol. 1975; 81:411-420
Clawson CC, White JG. Platelet interaction with bacteria. II. Fate of the bacteria. Am J Pathol. 1971; 65:381-397
Clawson CC, White JG. Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. Am J Pathol. 1971; 65:367-380
Kerrigan S, Cox D. Platelet-bacterial interactions as therapeutic targets in infective endocarditis. In: Breijo-Marquez FR (ed). : Intech Publishers; 2012
Plummer C, Wu H, Kerrigan SW, Meade G, Cox D, Ian Douglas CW. A serine-rich glycoprotein of Streptococcus sanguis mediates adhesion to platelets via GPIb. Br J Haematol. 2005; 129:101-109
Kerrigan SW, Clarke N, Loughman A, Meade G, Foster TJ, Cox D. Molecular basis for Staphylococcus aureus-mediated platelet aggregate formation under arterial shear in vitro. Arterioscler Thromb Vasc Biol. 2008; 28:335-340
Siegel I, Cohen S. Action of staphylococcal toxin on human platelets. J Infect Dis. 1964; 114:488-502
Schubert S, Schwertz H, Weyrich AS Staphylococcus aureus α-toxin triggers the synthesis of B-cell lymphoma 3 by human platelets. Toxins. 2011; 3:120-133
Jakubovics NS, Kerrigan SW, Nobbs AH Functions of cell surface-anchored antigen I/II family and Hsa polypeptides in interactions of Streptococcus gordonii with host receptors. Infect Immun. 2005; 73:6629-6638
Kerrigan SW, Jakubovics NS, Keane C Role of Streptococcus gordonii surface proteins SspA/SspB and Hsa in platelet function. Infect Immun. 2007; 75:5740-5747
Xiong YQ, Bensing BA, Bayer AS, Chambers HF, Sullam PM. Role of the serine-rich surface glycoprotein GspB of Streptococcus gordonii in the pathogenesis of infective endocarditis. Microb Pathog. 2008; 45:297-301
Takahashi Y, Konishi K, Cisar JO, Yoshikawa M. Identification and characterization of hsa, the gene encoding the sialic acid-binding adhesin of Streptococcus gordonii DL1. Infect Immun. 2002; 70:1209-1218
Keane C, Petersen H, Reynolds K Mechanism of outside-in αIIbβ3-mediated activation of human platelets by the colonizing bacterium, Streptococcus gordonii. Arterioscler Thromb Vasc Biol. 2010; 30:2408-2415
Petersen HJ, Keane C, Jenkinson HF Human platelets recognize a novel surface protein, PadA, on Streptococcus gordonii through a unique interaction involving fibrinogen receptor GPIIbIIIa. Infect Immun. 2010; 78:413-422
Keane C, Petersen HJ, Tilley DO Multiple sites on Streptococcus gordonii surface protein PadA bind to platelet GPIIbIIIa. J Thromb Haemost. 2013; 110:1278-1287
Haworth J, Jenkinson HF, Petersen H Concerted functions of Streptococcus gordonii surface protein PadA and Hsa mediate activation of human platelets and interactions with extracellular matrix. Cell Microbiol. 2016; https://doi.org/10.1111/cmi.12667
Mancini S, Menzi C, Oechslin F, Moreillon P, Entenza JM. Antibodies targeting Hsa and PadA prevent platelet aggregation and protect rats against experimental endocarditis induced by Streptococcus gordonii. Infect Immun. 2016; 84:3557-3563
Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. NICE Clinical Guideline No 64. 2008. https://www.nice.org.uk/guidance/cg64/chapter/recommendations (Accessed November 2016)
Thornhill MH, Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB. The effect of antibiotic prophylaxis guidelines on incidence of infective endocarditis. Can J Cardiol. 2016; 32
Thornhill MH, Dayer M, Lockhart PB Prophylaxis guidelines: Plea to NICE. Br Dent J. 2016; 221:2-3
Alderson P, Baker M. Prophylaxis guidelines: repeated points. Br Dent J. 2016; 220
Alderson P, Baker M. Prophylaxis guidelines: repeated points. Br Dent J. 2016; 220
Chambers JB, Thornhill M, Shanson D, Prendergast B. Antibiotic prophylaxis of endocarditis: a NICE mess. Lancet Infect Dis. 2016; 16:275-276
Chambers J, Thornhill M, Shanson D, Prendergast B. Antibiotic prophylaxis of endocarditis – Authors' reply. Lancet Infect Dis. 2016; 16:774-775
Million M, Grisoli D, Griffiths K, Raoult D. Antibiotic prophylaxis of endocarditis. Lancet Infect Dis. 2016; 16:773-774
Main BG, Adair SR. The changing face of informed consent. Br Dent J. 2015; 219:325-327
Thornhill MH, Dayer M, Lockhart PB A change in the NICE guidelines on antibiotic prophylaxis. Br Dent J. 2016; 221:112-114
Song M, O'Donnell JA, Bekhuis T, Spallek H. Are dentists interested in the oral-systemic disease connection? A qualitative study of an online community of 450 practitioners. BMC Oral Health. 2013; 13
Friedewald VE, Kornman KS, Beck JD The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol. 2009; 104:59-68

Oral hygiene as a risk factor in infective endocarditis

From Volume 44, Issue 9, October 2017 | Pages 877-890

Authors

Jennifer A Haworth

PhD

Academic Clinical Lecturer, Bristol Dental School, University of Bristol, Lower Maudlin Street, BS1 2LY, Bristol, UK

Articles by Jennifer A Haworth

Richard G Mears

BDS

General Dental Practitioner, Combe Road Dental Practice, 6 Combe Road, Portishead, BS20 6BJ and Clinical Teaching Fellow, Restorative Dentistry, Bristol Dental School, University of Bristol, Lower Maudlin Street, BS1 2LY, Bristol, UK

Articles by Richard G Mears

Howard F Jenkinson

PhD

Professor of Oral Microbiology, Bristol Dental School, University of Bristol, Lower Maudlin Street, BS1 2LY, Bristol, UK

Articles by Howard F Jenkinson

Steve W Kerrigan

PhD

Senior Lecturer in Pharmacology, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland

Articles by Steve W Kerrigan

Angela H Nobbs

PhD

Senior Lecturer in Oral Microbiology, Bristol Dental School, University of Bristol, Lower Maudlin Street, BS1 2LY, Bristol, UK

Articles by Angela H Nobbs

Abstract

There are many known associations between oral and systemic diseases. This review paper summarizes the proposed mechanisms underlying the links between dental disease and cardiovascular disease before introducing recent research regarding bacteria-platelet interactions. New protein factors have been identified on dental plaque bacteria. One of these, PadA, triggers blood to clot. This research provides new information about how Streptococcus bacteria and platelets interact and could lead to the development of new ways to control the formation of blood clots caused by micro-organisms that access the bloodstream.

CPD/Clinical Relevance: This article aims to provide the whole dental team with an overview of bacteria-platelet interactions. This is of particular relevance to infective endocarditis and the recent change in wording to the NICE antibiotic prophylaxis guidelines in the UK.

Article

The mouth is often referred to as a window into the health of the body, but the idea of oral diseases being a risk factor for systemic diseases is not a new concept. The importance of oral hygiene was noted by the Ancient Greeks1 and Hippocrates recorded two cases where eradication of mouth infections relieved patients of rheumatic joint problems.2 The British surgeon, William Hunter, is regarded as one of the first in the 20th century to emphasize the role of oral sepsis in leading to generalized diseases3 and removal of infected teeth was common. In contrast, the second half of the 20th century saw increased conservation and restoration of teeth, with relatively little published about possible links between oral and systemic diseases. However, a seminal study in 1989 reported that dental health was significantly worse in patients with acute myocardial infarction, after adjusting for risk factors.4 Subsequent papers re-ignited the debate and the turn of the 21st century saw a renewed scientific interest in the links between oral and systemic diseases, with increasing awareness that the mouth can act as a reservoir for pathogenic bacteria and their products.

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available

Already have an account? Sign in here